Transcat’s Strategic Acquisitions and Growth Potential Justify Buy Rating Despite Current Challenges
H.C. Wainwright analyst Scott Buck maintained a Buy rating on Transcat (TRNS – Research Report) today and set a price target of $126.00.Invest ...
Business Insider4d
Strong Financial Prospects and Strategic Risk Management Justify Buy Rating for HCA Healthcare
In a report released yesterday, Joanna Gajuk from Bank of America Securities maintained a Buy rating on HCA Healthcare (HCA – Research Report), with a price target of $380.00. Joanna Gajuk’s ...